当前位置: X-MOL 学术Tissue Eng. Part C Method › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
In Vitro Evaluation of Recombinant Bone Morphogenetic Protein-2 Bioactivity for Regenerative Medicine.
Tissue Engineering, Part C: Methods ( IF 3 ) Pub Date : 2019-09-01 , DOI: 10.1089/ten.tec.2019.0156
Stephanie L Fung 1 , Xiaohuan Wu 1 , Julian P Maceren 1 , Yong Mao 1 , Joachim Kohn 1
Affiliation  

This work is a systematic evaluation of the experimental parameters of the most widely used in vitro recombinant human bone morphogenetic protein-2 (rhBMP-2) activity assays. The variations in assays reported in the literature have challenged the reproducibility and translation of work using rhBMP-2 as a bone-inducing growth factor. By elucidating the effect of model cell line on the dose-dependent alkaline phosphatase response to rhBMP-2 induction and by establishing a correlation between protein activity and protein concentration by enzyme-linked immunosorbent assay using commercially available rhBMP-2, this work is a significant step toward developing an in vitro-in vivo correlation between quantified activity and clinical efficacy.

中文翻译:

重组骨形态发生蛋白2生物活性对再生医学的体外评估。

这项工作是对最广泛使用的体外重组人骨形态发生蛋白2(rhBMP-2)活性测定的实验参数的系统评价。文献中报道的测定方法的变化已经挑战了使用rhBMP-2作为骨诱导生长因子的可重复性和工作翻译。通过阐明模型细胞系对rhBMP-2诱导的剂量依赖性碱性磷酸酶反应的影响,并通过使用市售rhBMP-2的酶联免疫吸附法确定蛋白质活性与蛋白质浓度之间的相关性,这项工作具有重要意义。在定量活性和临床疗效之间建立体内外相关性的步骤。
更新日期:2019-11-01
down
wechat
bug